Australia's Polynovo rises on revenue growth as COVID-19 impact eases
06/04/2022 02:18
** Shares of medical device maker Polynovo Ltd PNV.AX soar
as much as 13% to A$1.22, on course for their best session since
Jan. 11, if gains hold
** Co reports revenue of A$12.26 million for the quarter
ended March, a 59.3% rise urn:newsml:reuters.com:*:nGLF4HxKnS
** Chairman David Williams attributes performance to
diminishing effects of COVID-19, more sales representatives and
wider geographical footprint
** Stock hits highest level since Feb. 17
** PNV down 29.2% YTD, as of last close
(Reporting by Harshita Swaminathan in Bengaluru)
((Harshita.Swaminathan@thomsonreuters.com))